Cue Biopharma, Inc. — Director's Dealing 2020

Aug 7, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Cue Biopharma, Inc. (CUE)
CIK: 0001645460
Period of Report: 2020-08-05

Reporting Person: Suri Anish (President and CSO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-08-05	Common Stock	M	800	$6.42	Acquired	35358	Direct
2020-08-05	Common Stock	S	800	$20.01	Disposed	34558	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-08-05	Stock Option (right to buy)	$6.42	M	800	Disposed	2029-03-06	Common Stock (800)	Direct

Footnotes

F1: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 24, 2020.

F2: This stock option grant becomes exercisable in eight equal semi-annual installments beginning September 6, 2019.